Innovation Pharmaceuticals Inc (IPIX)

[scottsmith]

You are omitting key parts of the discussion.

Regardless, I totally stand by my statement that failing to meet primary endpoints would be devastating for ipix. As per the link bio posted, compelling secondary endpoints are not enough to move into phase 3 or get fda drug approval.

Not meeting primary endpoints would mean FAILING the trial. IPIX cannot afford to FAIL a Brilacidin trial. I understand that you think that other trials are looking at duration, and that somehow that fact would make FAILING a trial ok. But you need to look at the real world and not only THE SCIENCE. In the real world, a big pharma will let ipix bleed and bleed after a TRIAL FAILURE. Ipix would be lucky to get pennies on the dollar at that point.

Case closed.